Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.
作者信息
DiNicolantonio James J, O'Keefe James H, McCarty Mark F
机构信息
Preventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas, USA.
Catalytic Longevity, Encinitas, California, USA.
出版信息
Open Heart. 2017 Sep 2;4(2):e000642. doi: 10.1136/openhrt-2017-000642. eCollection 2017.
Abstract
摘要
相似文献
1
Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.用营养保健品靶向治疗阿司匹林抵抗：一种降低心血管发病率和死亡率的可能策略。
Open Heart. 2017 Sep 2;4(2):e000642. doi: 10.1136/openhrt-2017-000642. eCollection 2017.
2
Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies.使用抗炎和抗氧化营养保健品及草药产品预防心血管疾病：临床前和临床研究综述
Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):145-157. doi: 10.2174/1872213X12666180815144803.
3
Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function.营养保健品在心血管预防中的作用：基于内皮功能研究的启示。
Cardiovasc Ther. 2010 Aug;28(4):187-201. doi: 10.1111/j.1755-5922.2010.00165.x. Epub 2010 Jun 14.
4
High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome.老年心血管疾病和代谢综合征患者中阿司匹林抵抗的高患病率。
J Geriatr Cardiol. 2016 Sep;13(6):531-6. doi: 10.11909/j.issn.1671-5411.2016.06.009.
5
Nutraceuticals--an emerging era in the treatment and prevention of cardiovascular diseases.营养保健品——心血管疾病治疗与预防的崭新时代。
Curr Pharm Biotechnol. 2006 Feb;7(1):15-23. doi: 10.2174/138920106775789647.
6
Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study.阿司匹林和他汀类药物在单纯高血压患者心血管疾病死亡一级预防中的疗效：一项韩国全国队列研究。
J Hypertens. 2017 May;35 Suppl 1:S33-S40. doi: 10.1097/HJH.0000000000001279.
7
Aspirin "resistance" and its impact on cardiovascular morbidity and mortality: it is real, clinically relevant and should be measured.阿司匹林“抵抗”及其对心血管发病率和死亡率的影响：它确实存在，具有临床相关性，且应该进行测定。
Heart. 2009 Aug;95(15):1223-4. doi: 10.1136/hrt.2008.157321. Epub 2009 Apr 26.
8
Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.2型糖尿病患者心血管疾病的预防：如何提高阿司匹林的临床疗效
Thromb Haemost. 2005 Jan;93(1):8-16. doi: 10.1160/TH04-07-0453.
9
Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.阿司匹林对糖尿病患者死亡率和发病率的影响。早期治疗糖尿病视网膜病变研究报告14。早期治疗糖尿病视网膜病变研究组。
JAMA. 1992 Sep 9;268(10):1292-300. doi: 10.1001/jama.1992.03490100090033.
10
[Aspirin resistance].[阿司匹林抵抗]
Brain Nerve. 2008 Nov;60(11):1357-64.
引用本文的文献
1
Preventing the development of severe COVID-19 by modifying immunothrombosis.通过调节免疫血栓来预防重症 COVID-19 的发生。
Life Sci. 2021 Jan 1;264:118617. doi: 10.1016/j.lfs.2020.118617. Epub 2020 Oct 20.
2
Dietary fats, blood pressure and artery health.膳食脂肪、血压与动脉健康。
Open Heart. 2019 Jun 25;6(1):e001035. doi: 10.1136/openhrt-2019-001035. eCollection 2019.
本文引用的文献
1
Aspirin resistance in coronary heart disease: Current understandings and strategies.冠心病中的阿司匹林抵抗：当前认识与策略
J Transl Int Med. 2016 Apr 1;4(1):7-10. doi: 10.1515/jtim-2016-0002. Epub 2016 Apr 14.
2
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.阿司匹林小剂量用于 2 型糖尿病患者的心血管事件一级预防：一项随机对照试验的 10 年随访结果。
Circulation. 2017 Feb 14;135(7):659-670. doi: 10.1161/CIRCULATIONAHA.116.025760. Epub 2016 Nov 15.
3
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.MD1003（高剂量生物素）治疗进展型多发性硬化症：一项随机、双盲、安慰剂对照研究。
Mult Scler. 2016 Nov;22(13):1719-1731. doi: 10.1177/1352458516667568. Epub 2016 Sep 1.
4
High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome.老年心血管疾病和代谢综合征患者中阿司匹林抵抗的高患病率。
J Geriatr Cardiol. 2016 Sep;13(6):531-6. doi: 10.11909/j.issn.1671-5411.2016.06.009.
5
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?不对称二甲基精氨酸是心血管疾病发病和死亡的既定中介危险因素——血液中该水平升高的患者是否应补充瓜氨酸？
Healthcare (Basel). 2016 Jul 8;4(3):40. doi: 10.3390/healthcare4030040.
6
Medical Application of Spirulina platensis Derived C-Phycocyanin.钝顶螺旋藻来源的C-藻蓝蛋白的医学应用
Evid Based Complement Alternat Med. 2016;2016:7803846. doi: 10.1155/2016/7803846. Epub 2016 May 11.
7
Carbonyl Compounds in the Gas Phase of Cigarette Mainstream Smoke and Their Pharmacological Properties.卷烟主流烟气气相中的羰基化合物及其药理特性。
Biol Pharm Bull. 2016;39(6):909-14. doi: 10.1248/bpb.b16-00025.
8
Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.牛磺酸补充降低高血压前期血压和改善血管功能：随机、双盲、安慰剂对照研究。
Hypertension. 2016 Mar;67(3):541-9. doi: 10.1161/HYPERTENSIONAHA.115.06624. Epub 2016 Jan 18.
9
Resveratrol inhibits collagen-induced platelet stimulation through suppressing NADPH oxidase and oxidative inactivation of SH2 domain-containing protein tyrosine phosphatase-2.白藜芦醇通过抑制NADPH氧化酶和含SH2结构域的蛋白酪氨酸磷酸酶-2的氧化失活来抑制胶原蛋白诱导的血小板刺激。
Free Radic Biol Med. 2015 Dec;89:842-51. doi: 10.1016/j.freeradbiomed.2015.10.413. Epub 2015 Oct 22.
10
Nox-2 up-regulation and platelet activation: Novel insights.Nox-2上调与血小板活化：新见解
Prostaglandins Other Lipid Mediat. 2015 Jul;120:50-5. doi: 10.1016/j.prostaglandins.2015.03.010. Epub 2015 Apr 4.
Zotero 插件